Home   Distributors   Careers   Contact

DESyne® X2 NOVOLIMUS™ Eluting Coronary Stent System

Stent Design

Exceptional Deliverability

Ultra Thin DESyne Stent

• Low profile stent delivery system for high flexibility and deliverability

• Lowest polymer and drug load


Clinical Results

5-year Proven Clinical Results (EXCELLA RCT)

Ordering Information

*  Data on file at Elixir Medical.

1 » Serruys P, et al,  A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: the SPIRIT II trial., EuroIntervention 2006.

2 » Meredith IT, et al, Clinical and angiographic results with the next-generation resolute stent system: a prospective, multicenter, first-in-human trial. JACC (2009).

3 » Meredith IT, Whitbourn R, Scott D, et al, PLATINUM QCA: EuroIntervention. 2011.

4 » Windecker, S. et al, (LEADERS): a randomised non inferiority trial; The Lancet 2008; 372 No. 9644: 1163-1173.

5 » Windecker S. et al, BioFlow II Trail, Circulation: Cardiovascular Intervention 2015.

6 » Meredith IT, Primary Endpoint Results of the EVOLVE Trial: A Randomized Evaluation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent, 2012.